Analgesic Efficacy of Parasternal Block Versus Parasternal Plus Serratus Anterior Plane Block After Coronary Bypass Surgery
Evaluation of the Analgesic Efficacy of Parasternal Block and Parasternal Plus Serratus Anterior Plane Block in Patients Undergoing Coronary Artery Bypass Grafting Surgery
1 other identifier
interventional
72
1 country
1
Brief Summary
This single-centre randomized clinical trial will compare two regional anaesthesia techniques for postoperative pain control in adult patients undergoing elective coronary artery bypass grafting (CABG) with sternotomy. All patients will receive a bilateral parasternal block as part of routine multimodal analgesia. Patients will be randomized to receive either parasternal block alone or a combination of parasternal block and serratus anterior plane block. The primary objective is to evaluate whether adding a serratus anterior plane block improves postoperative pain scores compared with parasternal block alone. Secondary objectives include comparing opioid consumption, need for rescue analgesics, opioid-related side effects, and length of stay in the intensive care unit and hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedFirst Submitted
Initial submission to the registry
December 10, 2025
CompletedFirst Posted
Study publicly available on registry
December 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedJanuary 13, 2026
January 1, 2026
3 months
December 10, 2025
January 11, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Total Tramadol Consumption
Cumulative dose of tramadol (mg) delivered by patient-controlled analgesia (PCA) in the first 24 hours post-extubation
24-hour post-extubation
Secondary Outcomes (2)
Resting Numeric Rating Scale (NRS) Pain Score
24 hour post-extubation
Dynamic Numeric Rating Scale (NRS) Pain Score
24-hour post-extubation
Study Arms (2)
Arm A: Parasternal Block
ACTIVE COMPARATORAfter induction of general anaesthesia and before skin incision, an ultrasound-guided bilateral parasternal intercostal plane block will be performed.
Arm B: Serratus Anterior Plane Block
EXPERIMENTALIn addition to the bilateral parasternal block described for the comparator arm, patients randomized to the experimental arm will receive an ultrasound-guided bilateral serratus anterior plane block.
Interventions
After induction of general anaesthesia and before skin incision, an ultrasound-guided bilateral parasternal intercostal plane block will be performed. A linear ultrasound probe will be placed parasagittally at the 2nd and 4th intercostal spaces approximately 2-3 cm lateral to the sternum. A block needle will be advanced in-plane beneath the pectoralis major muscle and above the internal intercostal muscles, and local anaesthetic (0.25% bupivacaine) will be injected bilaterally. Total dose will not exceed 2 mg/kg. Postoperative systemic analgesia (patient-controlled analgesia) will be identical in both groups.
In addition to the bilateral parasternal block described for the comparator arm, patients randomized to the experimental arm will receive an ultrasound-guided bilateral serratus anterior plane block. With the patient in supine position, the linear ultrasound probe will be placed over the 6th rib in the anterior axillary line. The needle will be advanced in-plane beneath the serratus anterior muscle and above the rib, and 0.25% bupivacaine will be injected into the fascial plane on each side. The combined total dose of local anaesthetic for both blocks will not exceed 2 mg/kg. Postoperative systemic analgesia will be identical in both groups.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- American Society of Anesthesiologists (ASA) physical status III-IV
- Scheduled for elective coronary artery bypass grafting surgery with sternotomy for coronary artery disease
- Able to provide written informed consent
You may not qualify if:
- Allergy or contraindication to local anaesthetic agents
- Minimally invasive bypass surgery or off-pump procedures planned
- Emergency cardiac surgery
- Preoperative Numeric Rating Scale (NRS) pain score ≥ 3
- Chronic opioid use in the preoperative period
- Infection or structural abnormality at planned block sites
- Any condition preventing postoperative pain assessment or PCA use (e.g. severe cognitive impairment)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Etlik City Hospital
Yenimahalle, Ankara, 06810, Turkey (Türkiye)
Related Publications (1)
Zengin EN, Yigit H, Cobas M, Salman N, Asli Demir Z. The analgesic effects of combined bilateral parasternal block and serratus anterior plane block for coronary artery bypass grafting surgery. BMC Anesthesiol. 2024 Aug 5;24(1):274. doi: 10.1186/s12871-024-02659-7.
PMID: 39103782RESULT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending anesthesiologist
Study Record Dates
First Submitted
December 10, 2025
First Posted
December 23, 2025
Study Start
September 1, 2025
Primary Completion
December 1, 2025
Study Completion
January 1, 2026
Last Updated
January 13, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- De-identified individual participant data underlying the primary publication may be shared upon reasonable request to the principal investigator after publication of the results.
- Access Criteria
- De-identified individual participant data underlying the primary publication may be shared upon reasonable request to the principal investigator after publication of the results.
De-identified individual participant data underlying the primary publication may be shared upon reasonable request to the principal investigator after publication of the results.